Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)Andries M. Bergman, Godefridus J. Peters, Herbert M. Pinedo|Drug Resistance Updates|2002Cited by 353
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa Severson, Andries M. Bergman|Cell Reports Medicine|2025Cited by 7